← Evidence map

ArticleBlood science (Baltimore, Md.)2026

Optimizing CMV prevention after allogenic hematopoietic stem cell transplantation: using CMV-specific cellular immunity to guide letermovir prophylaxis.

Sisi Zhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41438869